It's not like RAP at all. I profited on the takeover, but the technology never "took off" at all, unlike Painchek.
If PCK just ran the business as is and stopped spending on the infant app, they'd be profitable.
I'm happy for them to keep spending on infant and pursuing FDA approval(s). As painful as the long wait is, it'll be much more rewarding than just kicking back and enjoying what they have now.
PCK Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
